CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 4 Grant or award Director acquired 338 shares (grant or award)
- 4 Grant or award Director acquired 338 shares (grant or award)
- 4/A Derivatives Options or other derivatives
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Option exercise Pres. Diagnostics & Genom acquired 663 shares (option exercise)
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 2,504 shares at an average $378.80 ($948,516)
- 4 Option exercise SVP - General Counsel acquired 563 shares (option exercise)
- 4 Shares withheld for taxes Pres. Diagnostics & Genom gave up 1,214 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - General Counsel gave up 969 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 11,557 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,938 shares (to pay taxes)
Page 14 of 65 · 1,282 filings